A2M Management should have at least announced that they were in discussion with the US on an FDA approval to sell Infant Formula, instead of us reading the story on Fin Review?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.92 |
Change
-0.040(0.50%) |
Mkt cap ! $5.716B | |||
| Open | High | Low | Value | Volume |
| $7.99 | $7.99 | $7.83 | $1.456M | 184.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1989 | $7.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.92 | 2302 | 9 |
View Market Depth
| Last trade - 12.00pm 08/08/2025 (20 minute delay) ? |
| A2M (ASX) Chart |